SEFGAIA

Serial Number 99261829
686

Registration Progress

Application Filed
Jul 1, 2025
Under Examination
Approved for Publication
Jan 13, 2026
Published for Opposition
Jan 13, 2026
Registered

Attorney Assistance

Published for Opposition
Due: Feb 12, 2026 19 days

Trademark Image

SEFGAIA

Basic Information

Serial Number
99261829
Filing Date
July 1, 2025
Published for Opposition
January 13, 2026
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jan 13, 2026
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

Next Deadline
19 days remaining
Published for Opposition
Due Date
February 12, 2026
Extension Available
Until March 12, 2026

Application History

14 events
Date Code Type Description Documents
Jan 13, 2026 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 13, 2026 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 7, 2026 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 12, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 10, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 10, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 22, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 22, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 22, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 22, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 1, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 1, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 1, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005